Shantani Proteome Analytics

Pune, India Founded: 2010 • Age: 16 yrs
Drug discovery services are delivered via chemical-proteomics technologies.
Annual revenue $1.1M Latest available
Total funding $987,612 4 rounds
Employees 1 Tracked headcount
Investors 6 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Shantani Proteome Analytics

Shantani Proteome Analytics is a company based in Pune (India) founded in 2010. Shantani Proteome Analytics has raised $987.61 thousand across 4 funding rounds from investors including Entrepreneurship Development Institute of India, India Innovation Fund and Blume Ventures. The company has 1 employees as of May 05, 2024. Shantani Proteome Analytics operates in a competitive market with competitors including Somalogic, Nautilus Biotechnology, Amunix, Biognosys and Elektrofi, among others.

  • Headquarter Pune, India
  • Employees 1 as on 05 May, 2024
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Shantani Proteome Analytics Private Limited
  • Date of Incorporation 12 May, 2010
  • Jurisdiction Pune, Maharashtra, India
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.07 M (USD)
    121.89
    as on Mar 31, 2022
  • Net Profit
    $560.95 K (USD)
    275.22
    as on Mar 31, 2022
  • EBITDA
    $718.28 K (USD)
    279.91
    as on Mar 31, 2022
  • Total Equity Funding
    $987.61 K (USD)

    in 4 rounds

  • Latest Funding Round
    $181.61 K (USD), Seed

    Jan 12, 2015

  • Investors
  • Employee Count
    1

    as on May 05, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Shantani Proteome Analytics

Shantani Proteome Analytics has successfully raised a total of $987.61K across 4 strategic funding rounds. The most recent funding activity was a Seed round of $181.61 thousand completed in January 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Shantani Proteome Analytics

Shantani Proteome Analytics has secured backing from 6 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Entrepreneurship Development Institute of India, India Innovation Fund and Blume Ventures.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
India focused early stage mivro VC firm
Locked Locked Locked
Seed and early-stage investments are made across sectors in India.
Locked Locked Locked
Entrepreneurship education, research, and training are provided to diverse groups.
Locked Locked Locked
Premium access

Investor details for Shantani Proteome Analytics

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Shantani Proteome Analytics

Investments
Premium access

Investment portfolio details for Shantani Proteome Analytics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Shantani Proteome Analytics

Premium access

Detailed financials for Shantani Proteome Analytics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Shantani Proteome Analytics Comparisons

Shantani Proteome Analytics Primary company
Description
Drug discovery services are delivered via chemical-proteomic...
Location
Pune, India
Founded Year
2010
Annual Revenue
$1.07 M (USD)
Net Profit
$560.95 K (USD)
EBITDA
$718.28 K (USD)
Employees
1
As of 2024
Premium access

Peer comparison for Shantani Proteome Analytics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Shantani Proteome Analytics

Shantani Proteome Analytics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Somalogic, Nautilus Biotechnology, Amunix, Biognosys and Elektrofi, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Protein-based assays are developed for life science research.
Locked Locked Locked
A proteomics platform is developed for analyzing the human proteome.
Locked Locked Locked
Peptide-based therapeutics are developed for cancers and immune disorders.
Locked Locked Locked
Proteomics services are delivered via discovery and targeted platforms.
Locked Locked Locked
Digital platform transforming the delivery of biologic medicines
Locked Locked Locked
Provider tools to help researchers with protein analysis
Premium access

Detailed competitors of Shantani Proteome Analytics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Shantani Proteome Analytics

Premium access

Complete news archive for Shantani Proteome Analytics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shantani Proteome Analytics

Shantani Proteome Analytics was founded in 2010 and raised its 1st funding round 1 year after it was founded.

Shantani Proteome Analytics is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.

Shantani Proteome Analytics is a funded company, having raised a total of $987.61K across 4 funding rounds to date.

As of May 05, 2024, the latest employee count at Shantani Proteome Analytics is 1.

Annual revenue of Shantani Proteome Analytics is $1.07M as on Mar 31, 2022.

Founded in 2010 and based in Pune, India, Shantani Proteome Analytics operates in the biotechnology sector, focusing on drug discovery and development. Proprietary chemical proteomics platforms, including SCLS and UPT workflows, are utilized to analyze targets and mechanisms of bioactive molecules. These integrate chemical biology, biophysics, and cell molecular biology approaches to support research operations.

Shantani Proteome Analytics's top competitors include Somalogic, Nautilus Biotechnology and Elektrofi.

Shantani Proteome Analytics has 6 investors. Key investors include Entrepreneurship Development Institute of India, India Innovation Fund, Blume Ventures, Vara Prasad Reddy, and Sravanthi Reddy.

The valuation of Shantani Proteome Analytics is $2.38M as of Jun 2013.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available